SCHEMBL19377014

SCHEMBL19377014

CC(NC(=O)Nc1ccc(S(=O)(=O)Cc2ccc3c(c2)CN(C)C3)cc1)c1ccccc1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ USP2 O75604 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ LMNA P02545 1/20 0.39
▸ ROCK2 O75116 2/20 0.38
▸ IDH1 O75874 1/20 0.38
▸ DRD2 P14416 1/20 0.38
▸ HTR2A P28223 1/20 0.38
▸ HTR2C P28335 1/20 0.38
▸ DRD3 P35462 1/20 0.38
▸ HTR6 P50406 1/20 0.38
▸ HCRTR1 O43613 1/20 0.37
▸ RORC P51449 2/20 0.36
▸ SCN3A Q9NY46 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ GRM4 Q14833 2/20 0.36
▸ NAMPT P43490 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19377308 0.93 ROCK2 (0.43) MEN1KMT2AUSP2GAAMAPT
SCHEMBL19377587 0.90 DRD2 (0.38) MEN1KMT2AUSP2GAAMAPT
SCHEMBL19377222 0.88 IDH1 (0.47) ROCK2IDH1
SCHEMBL19377317 0.87 HSD17B10 (0.48) MEN1KMT2AALDH1A1ROCK2IDH1
SCHEMBL19377210 0.87 HSD17B10 (0.48) MEN1KMT2AALDH1A1ROCK2IDH1
SCHEMBL19377183 0.87 HSD17B10 (0.48) MEN1KMT2AALDH1A1ROCK2IDH1
SCHEMBL19377186 0.87 ROCK2 (0.43) MEN1KMT2AUSP2GAAMAPT
SCHEMBL19377340 0.87 ROCK2 (0.43) MEN1KMT2AUSP2GAAMAPT
SCHEMBL19377185 0.87 ROCK2 (0.43) MEN1KMT2AUSP2GAAMAPT
SCHEMBL19377448 0.87 MLNR (0.40) ALDH1A1LMNAIDH1DRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3390355-B1 BENZENESULFONYL-ASYMMETRIC UREAS AND MEDICAL USES THEREOF HELSINN HEALTHCARE SA (CH) 2022-12-28 — — EP claimed
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US claimed
EP-3390355-B1 BENZENESULFONYL-ASYMMETRIC UREAS AND MEDICAL USES THEREOF HELSINN HEALTHCARE SA (CH) 2022-12-28 — — EP disclosed
EP-3390355-B1 BENZENESULFONYL-ASYMMETRIC UREAS AND MEDICAL USES THEREOF HELSINN HEALTHCARE SA (CH) 2022-12-28 — — EP disclosed
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US disclosed
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US disclosed
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof HELSINN HEALTHCARE SA (CH) 2017-09-28 — — US disclosed
WO-2017162390-A1 BENZENESULFONYL-ASYMMETRIC UREAS AND MEDICAL USES THEREOF HELSINN HEALTHCARE SA (CH) 2017-09-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170275301-A1 Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof UTS2R, GHSR, GRPR MEN1 3276/4885KMT2A 3175/4885USP2 89/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback